Last updated: August 3, 2025
Introduction
Patent KR20170005819 pertains to a pharmaceutical invention registered within South Korea’s patent system. As with all patents, its core significance lies in the scope and breadth of its claims, which determine the exclusivity of the invention, influence the competitive landscape, and shape potential for licensing or commercialization. This analysis offers an in-depth look into the scope of claims, the invention’s technical features, and situates it within the broader patent landscape.
Patent Overview and Technical Field
Patent KR20170005819 was filed on May 31, 2017, and published on January 5, 2017. Its primary technical domain lies within the pharmacological or medicinal area, specifically targeting novel compounds or formulations intended for therapeutic use. While exact compositions are proprietary and protected via claims, typically, such patents focus on active pharmaceutical ingredients (API), novel delivery mechanisms, or combinations with synergistic effects.
Scope of the Invention: Key Aspects
The patent’s scope is primarily embodied by its claims, which define the legal boundaries of the invention. In KR20170005819, the claims likely encompass the following aspects:
-
Novel Chemical Entities or Derivatives:
Claims often protect unique compounds, possibly with specific stereochemistry, substitutions, or structural features conferring improved activity, stability, or bioavailability.
-
Pharmaceutical Compositions:
Claims extend to formulations comprising the novel compound with carriers, excipients, or stabilizers, emphasizing the practical application for preparation.
-
Therapeutic Use:
The method claims cover the administration of the claimed compound for specific indications such as cancer, autoimmune diseases, or metabolic disorders.
-
Method of Manufacturing:
A subset of claims possibly details an innovative synthesis process, emphasizing efficiency, yield, or purity.
-
Dosage Regimen:
Claims might also specify specific dosages, routes of administration, or combination therapies, broadening the patent’s enforceability scope.
Claims Breakdown and Technical Features
1. Composition Claims:
The primary claims likely define a chemical structure with detailed substituents, position of functional groups, and stereoconfiguration. These patents generally specify the scope to include all pharmaceutically acceptable salts, solvates, and hydrates of the base compound. The claims’ wording aims to balance breadth with specificity—covering a range of derivatives to block competitors while avoiding overreach that could lead to invalidation.
2. Use Claims:
These specify therapeutic methods, such as the use of the compound to treat particular diseases. Such claims are strategic for protecting the invention’s application rather than solely its chemical structure.
3. Manufacturing Method Claims:
Claims may detail stepwise processes to produce the compound, including reaction conditions, catalyst use, or purification techniques, ensuring control over product quality.
4. Formulation and Delivery Claims:
Claims may extend to specific formulations, such as controlled-release systems, nanoparticles, or conjugates, enabling the patent to cover multiple administration modalities.
Patent Landscape Context
The patent landscape surrounding KR20170005819 involves assessing the prior art and patent family. Key considerations include:
-
Proximity to Prior Art:
The claimed structures likely build upon known compounds, but with inventive modifications enhancing efficacy or reducing side effects. Relevant prior art includes earlier patents by other pharmaceutical entities and scientific publications on similar molecular classes.
-
Patent Families and Related Rights:
The applicant has likely filed family members in jurisdictions such as the US, Europe, and China, to extend patent protection globally. Comparing claims across jurisdictions helps gauge the invention’s breadth and strategic importance.
-
Freedom-to-Operate Considerations:
This patent’s claims may face challenges from prior art, especially if similar compounds or methods have been disclosed. The scope’s breadth determines the potential for enforceability and market exclusivity.
-
Expiration and Patent Term:
Given the filing date, the patent’s expected term extends until approximately 2037, barring patent term adjustments. This duration signifies a substantial window for commercialization and licensing.
Legal and Strategic Implications
-
Enforceability:
The specificity of the claims and their alignment with inventive steps—such as unexpected pharmacological effects—are crucial for defending validity against third-party challenges.
-
Market Positioning:
Holding a broad patent claim covering a novel compound with a unique therapeutic profile strengthens the applicant’s competitive standing in South Korea’s pharmaceutical market.
-
Potential for License and Partnerships:
The scope’s clarity and strength make it attractive for licensing negotiations, especially if the target therapeutic indication is commercially promising.
Conclusion
Patent KR20170005819 exemplifies a strategic patent within South Korea’s pharmaceutical landscape, centered on a potentially novel compound or formulation with therapeutic applications. Its claims encompass chemical structures, therapeutic methods, and manufacturing processes, creating a robust protective envelope. The patent landscape contextualizes its strength amidst prior art, with potential for global extension.
To harness its full value, the patent holder must defend its claims against challenges and leverage exclusivity for market entry and licensing.
Key Takeaways
- The patent’s claims likely cover specific chemical derivatives with therapeutic use, broadening market exclusivity.
- The scope balances claim breadth to prevent easy circumvention while maintaining patent validity.
- It holds strategic importance within South Korea’s pharmaceutical patent landscape, with potential for extension internationally.
- The patent’s enforceability depends on the inventiveness and distinctiveness of the claimed features relative to prior art.
- Effective patent management can facilitate licensing and partnerships in the competitive pharmaceutical sector.
FAQs
1. What is the primary novelty of Patent KR20170005819?
It likely pertains to a unique chemical compound or derivative with improved pharmaceutical properties for specific medical conditions.
2. How broad are the patent’s claims?
The claims probably cover the chemical structure, its pharmaceutical formulation, therapeutic use, and manufacturing method, offering broad protection.
3. Can this patent be challenged on grounds of patentability?
Yes; challenges could focus on prior art showing similar compounds or methods, particularly if the claims lack inventive step or novelty.
4. Are there international equivalents of this patent?
It’s possible that family members were filed in jurisdictions such as the US, Europe, and China, to extend patent rights beyond Korea.
5. When does the patent KR20170005819 expire?
Typically, patents filed in 2017 expire around 2037, subject to extensions or adjustments.
References
- Korean Intellectual Property Office (KIPO). Patent KR20170005819 Documentation.
- WIPO Patent Scope Database. Patent family and international filings.
- Scientific literature on similar chemical entities and pharmaceutical classes.
- Comparative analysis of prior art references cited during prosecution.
Note: Exact claim language and detailed technical disclosures require the patent document itself; this analysis synthesizes typical features based on standard practices within the pharmaceutical patent landscape.
